- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05827692
Impact of Forest Baths on Emotional Well-being in People With Sub-clinical Symptomatology of Anxiety and Depression (NAT-UAB)
April 12, 2023 updated by: Laura Comendador-Vazquez
UAB-CAN RULL 2022 Study: Impact of Forest Baths on Emotional Well-being in People With Sub-clinical Symptomatology of Anxiety and Depression
The investigators intend to evaluate patients aged 18 to 99 years with symptoms of anxiety and/or mild depression.
A randomized controlled clinical trial will be carried out to evaluate the impact of the guided practice of forest bathing.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The practice of Shinrin-Yoku, also known as Forest Bathing, is an outdoor therapeutic modality with growing evidence suggesting positive effects on the psychological well-being and general health of individuals.
However, its benefits have been studied mainly in Asian countries, needing further research to assess whether its benefits are also generalizable to other European-Mediterranean regions.
To explore this question, the investigators intend to evaluate patients aged 18 to 99 years with symptoms of anxiety and/or mild depression.
A randomized controlled clinical trial will be carried out to evaluate the impact of the guided practice of forest bathing.
The participants will be randomly distributed in two arms, with a crossover design: arm A intervention + control; arm B control + intervention.
Participation in this study consists of the execution of two sessions of guided forest bathing practice, and the completion of online evaluation forms before and after each session of guided forest bathing practice, for 24 hours afterwards, as well as before and after the program as a whole.
The study includes clinical assessments, emotional well-being, social support and other complementary indicators.
For hypothesis testing, a linear model of univariate analysis of variance intrasubject design will be applied to the dependent variables, with three phase conditions (pre, post and follow-up) and two treatment conditions (intervention vs. control).
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laura Comendador Vazquez
- Phone Number: 622054658
- Email: Laura.Comendador@uab.cat
Study Locations
-
-
Barcelona
-
Sabadell, Barcelona, Spain, 08206
- Recruiting
- Coloma Moreno Quiroga
-
Contact:
- Coloma Moreno Quiroga
- Email: CMoreno@tauli.cat
-
Principal Investigator:
- Laura Comendador Vazquez
-
Sub-Investigator:
- Antoni Sanz Ruiz, PhD
-
Sub-Investigator:
- Corel Mateo Canedo
-
Sub-Investigator:
- Neus Crespo Puig
-
Sub-Investigator:
- Miquel Cirera i Perich, PhD
-
Sub-Investigator:
- Eva Sanchez Perez
-
Sub-Investigator:
- Maria Paola Jimenez Villamizar
-
Sub-Investigator:
- Marta Korniyenko Korzhylova
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Men or women aged 18 to 65 years.
- Voluntary signature of informed consent.
- Symptomatology of anxiety and/or mild depression with mild interference in daily functioning.
- Motivation, attitude and ability to work in a group.
- Receptive attitude to learning new skills and sharing experiences.
Exclusion Criteria:
- Serious psychiatric disorder: Major depressive disorder with or without psychotic symptoms, uncompensated major depressive episode, dysthymic disorder, presence of suicidal ideation or suicide attempts, personality disorder.
- Lack of knowledge of Catalan and Spanish.
- Disconformity with acceptable standards of conduct.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Forest Bath Intervention group A
The intervention consists of 2 sessions of approximately 2 hours duration and fortnightly frequency.
In this context, it is guaranteed that patients will receive the care, visits and treatments usually used in people who have presented their clinical situation.
The only difference between participating or not in the intervention is the participation in the practice of forest baths and the performance of some additional assessments, i.e. not routinely performed, which are part of this project.
The investigators will be responsible for providing an overview of the study to eligible patients interested in participating.
Before proceeding to start the intervention, an informed consent will be given to the patients, in which a description of the characteristics of the sessions will be provided.
|
The forest bath sessions will be led by a specialized guide and will be conceived as a silent walk of about 3 km along a path and forest track with an average gradient of 3%, with three 10-minute stops (at the beginning, in the middle and at the end) to practice deep breathing and awareness of the 5 senses.
|
|
Experimental: Forest Bath Intervention group B
The intervention consists of 2 sessions of approximately 2 hours duration and fortnightly frequency.
In this context, it is guaranteed that patients will receive the care, visits and treatments usually used in people who have presented their clinical situation.
The only difference between participating or not in the intervention is the participation in the practice of forest baths and the performance of some additional assessments, i.e. not routinely performed, which are part of this project.
The investigators will be responsible for providing an overview of the study to eligible patients interested in participating.
Before proceeding to start the intervention, an informed consent will be given to the patients, in which a description of the characteristics of the sessions will be provided.
|
The forest bath sessions will be led by a specialized guide and will be conceived as a silent walk of about 3 km along a path and forest track with an average gradient of 3%, with three 10-minute stops (at the beginning, in the middle and at the end) to practice deep breathing and awareness of the 5 senses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Anxiety scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Generalized Anxiety Scale (GAD-7).
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Depression scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Patient Health Questionnaire (PHQ-9).
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Well-Being scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Emotional Well-Being Scale
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Social support scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
OSLO Scale 3
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in State Mindfulness scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
State Mindfulness Scale (SMS)
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Affect scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Positive and Negative Affect Checklist (PANAS-SF).
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Mood scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Profile of Mood States (POMS)
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Stress scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Ad hoc perceived stress item
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
|
Change in Affective variables scores
Time Frame: Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Self-Assessment Manikin (SAM)
|
Pre-intervention, intrasession, intersession, post-intervention and follo-up evaluations are planned for 1 month. The assessments will be carried out before and after the intervention with a maximum duration of 45 minutes.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Laura Comendador Vázquez, Corporación Parc Taulí
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 13, 2022
Primary Completion (Anticipated)
June 18, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
March 21, 2023
First Submitted That Met QC Criteria
April 12, 2023
First Posted (Actual)
April 25, 2023
Study Record Updates
Last Update Posted (Actual)
April 25, 2023
Last Update Submitted That Met QC Criteria
April 12, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/3020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Well-being
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Aydin Adnan Menderes UniversityCompleted
-
Clover LinkCompletedPsychological Well BeingFrance
-
University of Wisconsin, MadisonTempleton World Charity FoundationRecruiting
-
University of RochesterCenters for Disease Control and PreventionActive, not recruitingWell-Being, PsychologicalUnited States
-
Ege UniversityCompletedPsychological Resilience | Psychological Well-beingTurkey (Türkiye)
-
Clover LinkRecruitingPsychological Well BeingFrance
-
Penn State UniversityNot yet recruiting
-
Agri Ibrahim Cecen UniversityCompleted
Clinical Trials on Intervention group A
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
University of Missouri-ColumbiaNorthern Arizona UniversityTerminatedPhysical ActivityUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
University of Alabama at BirminghamPackHealth/AmgenCompletedMultiple MyelomaUnited States
-
Region StockholmKarolinska InstitutetNot yet recruiting
-
University of Sao PauloFederal University of São PauloCompletedRenal Insufficiency, ChronicBrazil
-
Riphah International UniversityCompletedPost-Thyroidectomy HypoparathyroidismPakistan
-
Riphah International UniversityCompletedIliotibial Band SyndromePakistan
-
Johns Hopkins UniversityRobert Wood Johnson FoundationCompletedViolenceUnited States
-
Pontificia Universidade Católica do Rio Grande...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.RecruitingFrailty | Aging | Physical DisabilityBrazil